Genomic testing can help identify important molecular features of a cancer that may not be visible through routine evaluation alone. This added information may help physicians better understand the disease and consider more personalized treatment options.
In many cases, yes. Testing may help uncover biomarkers or other findings that can support treatment planning, including targeted therapies, immunotherapy strategies, or other next-step decisions based on the biology of the cancer.
No. Genomic testing can be important in both common and rare cancers. It may provide useful information across a wide range of solid tumors and hematologic malignancies, depending on the clinical situation.
When facing cancer, more complete information can help reduce uncertainty and support better-informed decisions. Testing may give physicians and patients a clearer picture of the disease and help guide a more individualized care plan.
Cancer is not the same in every patient. Even when two people have the same diagnosis, the molecular features of their disease may be different. Genomic testing helps look more closely at those differences, giving the care team more information that may help support diagnosis, prognosis, and treatment planning.
Modern cancer care increasingly looks beyond the name of the disease alone. Testing can help physicians better understand the unique biology of a patient’s cancer and determine whether there are findings that may be relevant to targeted therapy, immunotherapy, clinical trial consideration, or broader treatment strategy.
Testing matters most when it can be used as part of real patient care. Access to the right test, the right information, and the right support can make a meaningful difference during a difficult time. For patients and families, understanding why testing matters can make the process feel more clear, more purposeful, and less overwhelming.
Genomic testing is designed to provide more information about the biology of the disease. That information may help the care team make more informed decisions.
Some results may point to treatment options, while others may provide diagnostic or prognostic insight. Even when a result does not immediately change therapy, it may still add important clinical understanding.
Results can help patients have more meaningful discussions with their physicians about diagnosis, treatment options, expectations, and possible next steps.
The value of testing depends on the type of cancer, the clinical setting, available specimen material, and the patient’s overall treatment plan. A physician can help determine which test is most appropriate.
For patients and families, genomic testing can provide a deeper understanding of cancer and help support more informed care decisions. At an important moment in the treatment journey, better molecular insight may help bring greater clarity, confidence, and direction